Common Pediatric Skin Lesions: A Comprehensive Review of the Current Literature

Faryan Jalalabadi1, Jeffrey G Trost1, Joshua A Cox1

  • 1Division of Plastic and Reconstructive Surgery, Baylor College of Medicine, Houston, Texas.

Insights

Diagnosing pediatric skin conditions is difficult. This article details common pediatric vascular, cystic, and pigmented lesions, aiding plastic surgeons in diagnosis and treatment.

Area of Science:

  • Dermatology
  • Pediatric Surgery
  • Plastic Surgery

Background:

  • Pediatric dermatologic disease diagnosis and treatment present unique challenges.
  • A foundational understanding of common pediatric cutaneous lesions is crucial for plastic surgery practice.

Purpose of the Study:

  • To describe common vascular, cystic, and pigmented cutaneous lesions in children.
  • To provide essential knowledge for plastic surgeons managing pediatric skin conditions.

Main Methods:

  • Review of common pediatric cutaneous lesions.
  • Discussion of epidemiology, pathogenesis, clinical course, and management options for each lesion type.

Main Results:

  • Identification of key vascular lesions in pediatric patients.
  • Characterization of common cystic lesions in children.
  • Overview of prevalent pigmented lesions encountered in pediatric dermatology.

Conclusions:

  • Comprehensive knowledge of pediatric skin lesions improves diagnostic accuracy.
  • Effective management strategies for common pediatric cutaneous conditions are outlined.
  • This review serves as a vital resource for plastic surgeons in pediatric dermatologic practice.

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.5K
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
6.0K
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
4.1K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
641
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
354
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
312